Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: A multicenter phase II study

W. J. Gradishar, L. A. Meza, B. Amin, D. Samid, T. Hill, Y. M. Chen, E. E. Lower, P. K. Marcom, Syma Iqbal

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: A multicenter phase II study'. Together they form a unique fingerprint.